Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
ZonMW subsidieert innovatief onderzoek naar dravetsyndroom
mei 2018 | Epilepsie